3Z

3Z is a Reykjavik-based drug discovery company. 3Z is accelerating preclinical research on its lead candidate treatments for ADHD and insomnia. Using its unique zebrafish screening platform, 3Z has identified novel and repurposed therapies for these indications; the platform allows for cost-effective, high-volume screens in vivo.